Concepedia

Publication | Open Access

Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise

26

Citations

19

References

2017

Year

Abstract

In this 24-week study, once-daily evogliptin monotherapy significantly improved glycaemic control and was well tolerated in patients with T2D.

References

YearCitations

Page 1